A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle
Year: 2008
Type: article
Abstract: Protein kinase Calpha (PKCalpha) has been implicated in cancer, but the mechanism is largely unknown. Here, we show that PKCalpha promotes head and neck squamous cell carcinoma (SCCHN) by a feed-forward network leading to cell cycle deregulation. PKCalpha inhibitors decrease proliferation in SCCHN cell lines and xenografted tumors. PKCalpha inhibition or depletion in tumor cells decreases DNA synthesis by suppressing extracellular signal-regulated kinase phosphorylation and cyclin E synthesis. Additionally, PKCalpha down-regulates miR-15a, a microRNA that directly inhibits protein synthesis of cyclin E, as well as other cell cycle regulators. Furthermore, both PKCalpha and cyclin E protein expression are increased in primary tumors, and PKCalpha inversely correlates with miR-15a expression in primary tumors. Finally, PKCalpha is associated with poor prognosis in SCCHN. These results identify PKCalpha as a key regulator of SCCHN tumor cell growth by a mechanism involving activation of mitogen-activated protein kinase, an initiator of the cell cycle, and suppression of miR-15a, an inhibitor of DNA synthesis. Although the specific components may be different, this type of feed-forward loop network, consisting of a stimulus that activates a positive signal and removes a negative brake, is likely to be a general one that enables induction of DNA synthesis by a variety of growth or oncogenic stimuli.
Source: Cancer Research
Institutions: University of Chicago, Vanderbilt University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Awards: Modulation of Head and Neck Cancer by Protein Kinase C, Molecular signatures of HNSCC in response to targeted therapies, G3681157002, G4492874890, MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCER, G5531283457, CARCINOGENESIS AND NOVEL THERAPEUTICS IN ORAL CANCER, Oral Cancer, Chemoprevention, and Anti-Angiogenesis
OpenAlex ID: W2112944159
